Skip to content

Peer-reviewed article

Should testing for BRCA1/2 mutations be permitted in children?

By John D. LantosJanuary 1, 2008in Family Practice News

About the author

John D. Lantos is a pediatrician and bioethicist writing on AI in medicine, neonatal intensive care, and end-of-life decisions. His essays appear in JAMA, JAMA Pediatrics, the Hastings Center Report, the New England Journal of Medicine, and Aeon. Read more about John.

The full archiveSubscribe